Mirae Asset Global Investments Co., Ltd. Sarepta Therapeutics, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$54.3 Billion
Q1 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 90,945 shares of SRPT stock, worth $13.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

90,945

Previous 43,050 111.25%

Holding current value

$13.9 Million

Previous $4.15 Million 183.62%

% of portfolio

0.02%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$93.7 - $141.53 $4.49 Million - $6.78 Million	47,895 Added 111.25%	90,945 $11.8 Million
Q4 2023 Jan 24, 2024	SELL	$67.31 - $124.76 $3.55 Million - $6.59 Million	-52,815 Reduced 55.09%	43,050 $4.15 Million
Q3 2023 Oct 26, 2023	BUY	$102.5 - $123.59 $488,207 - $588,659	4,763 Added 5.23%	95,865 $11.6 Million
Q2 2023 Aug 10, 2023	SELL	$106.4 - $157.19 $144,810 - $213,935	-1,361 Reduced 1.47%	91,102 $10.4 Million
Q1 2023 May 04, 2023	BUY	$117.53 - $155.99 $479,522 - $636,439	4,080 Added 4.62%	92,463 $12.7 Million

Q4 2022 Feb 09, 2023	SELL	$100.86 - $132.13 $3.75 Million - $4.91 Million	-37,147 Reduced 29.59%	88,383 $11.5 Million
Q3 2022 Nov 10, 2022	BUY	$75.71 - $119.24 $901,554 - $1.42 Million	11,908 Added 10.48%	125,530 $13.9 Million
Q2 2022 Jul 26, 2022	SELL	$62.69 - $88.44 $1.24 Million - $1.75 Million	-19,781 Reduced 14.83%	113,622 $8.52 Million
Q1 2022 May 10, 2022	SELL	$63.15 - $90.42 $1.37 Million - $1.97 Million	-21,768 Reduced 14.03%	133,403 $10.4 Million
Q4 2021 Feb 08, 2022	SELL	$77.28 - $99.42 $1.56 Million - $2.01 Million	-20,226 Reduced 11.53%	155,171 $14 Million
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $2.2 Million - $3.09 Million	33,424 Added 23.54%	175,397 $16.2 Million
Q2 2021 Aug 11, 2021	BUY	$69.38 - $86.75 $5.94 Million - $7.43 Million	85,670 Added 152.16%	141,973 $11 Million
Q1 2021 May 13, 2021	BUY	$72.25 - $168.95 $1.74 Million - $4.08 Million	24,143 Added 75.07%	56,303 $4.2 Million
Q4 2020 Feb 10, 2021	BUY	$125.56 - $178.74 $1.1 Million - $1.56 Million	8,724 Added 37.22%	32,160 $5.48 Million
Q3 2020 Nov 12, 2020	BUY	$127.12 - $172.34 $774,415 - $1.05 Million	6,092 Added 35.12%	23,436 $3.29 Million
Q2 2020 Aug 11, 2020	BUY	$93.0 - $171.7 $190,278 - $351,298	2,046 Added 13.37%	17,344 $2.78 Million
Q1 2020 May 12, 2020	BUY	$82.38 - $131.64 $197,712 - $315,935	2,400 Added 18.61%	15,298 $1.5 Million
Q4 2019 Feb 12, 2020	BUY	$76.53 - $135.58 $293,722 - $520,356	3,838 Added 42.36%	12,898 $1.66 Million
Q3 2019 Nov 12, 2019	BUY	$72.81 - $156.91 $239,253 - $515,606	3,286 Added 56.91%	9,060 $682,000
Q2 2019 Aug 13, 2019	BUY	$112.21 - $151.95 $177,179 - $239,929	1,579 Added 37.64%	5,774 $877,000
Q1 2019 May 13, 2019	BUY	$106.67 - $151.68 $447,480 - $636,297	4,195 New	4,195 $500,000

Others Institutions Holding SRPT

# of Institutions

470

Shares Held

79.3M

Call Options Held

4.23M

Put Options Held

1.21M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $13.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Sarepta Therapeutics, Inc. Transaction History